Pharvaris
Develops oral deucrictibant formulations to treat and prevent hereditary angioedema attacks.
$35.40
After-hours close+0.05 (+0.14%)
At close$35.35(−4.46%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.84 | — | — |
| Aug 2026 | −$0.75 | −$0.81 | −8.5% |
| Aug 2026 | −$0.75 | — | — |
| May 2026 | −$0.82 | −$0.70 | +14.8% |
| Apr 2026 | −$0.71 | −$0.85 | −18.3% |
| Nov 2025 | −$0.78 | −$0.70 | +10.3% |
The latest year is open to everyone — the 30 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Apr 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Apr 2023 | |||
| Dec 2022 | |||
| Jul 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Jul 2021 | |||
| May 2021 | |||
| Apr 2021 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Dec 2018 | |||
| Sep 2018 | |||
| Jun 2018 | |||
| Mar 2018 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 11, 2026 | −$0.84 | — | — | — | — | — |
| Aug 12, 2026 | −$0.75 | −$0.81 | −8.5% | — | — | — |
| Aug 11, 2026 | −$0.75 | — | — | — | — | — |
| May 12, 2026 | −$0.82 | −$0.70 | +14.8% | — | — | — |
| Apr 2, 2026 | −$0.71 | −$0.85 | −18.3% | — | — | — |
| Nov 12, 2025 | −$0.78 | −$0.70 | +10.3% | — | — | — |
The latest year is open to everyone — the 30 quarters behind it read with an account. Sign in | ||||||
| Aug 12, 2025 | ||||||
| May 13, 2025 | ||||||
| Mar 31, 2025 | ||||||
| Nov 13, 2024 | ||||||
| Aug 14, 2024 | ||||||
| May 8, 2024 | ||||||
| Apr 3, 2024 | ||||||
| Nov 2, 2023 | ||||||
| Aug 7, 2023 | ||||||
| May 8, 2023 | ||||||
| Apr 5, 2023 | ||||||
| Dec 8, 2022 | ||||||
| Jul 1, 2022 | ||||||
| May 11, 2022 | ||||||
| Mar 29, 2022 | ||||||
| Nov 10, 2021 | ||||||
| Jul 30, 2021 | ||||||
| May 26, 2021 | ||||||
| Apr 30, 2021 | ||||||
| Sep 30, 2020 | ||||||
| Jun 30, 2020 | ||||||
| Mar 31, 2020 | ||||||
| Dec 31, 2019 | ||||||
| Sep 30, 2019 | ||||||
| Jun 30, 2019 | ||||||
| Mar 31, 2019 | ||||||
| Dec 31, 2018 | ||||||
| Sep 30, 2018 | ||||||
| Jun 30, 2018 | ||||||
| Mar 31, 2018 | ||||||